메뉴 건너뛰기




Volumn 214, Issue 9-10, 2009, Pages 800-810

Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case

Author keywords

Antibody conjugates; Cancer therapy; Cytokines; EDB; Fibronectin

Indexed keywords

DOXORUBICIN; FIBRONECTIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; MELPHALAN; RITUXIMAB; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

EID: 68349091432     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2009.06.005     Document Type: Review
Times cited : (27)

References (120)
  • 1
    • 27144449009 scopus 로고    scopus 로고
    • Monoclonal antibody therapy of cancer
    • Adams G.P., and Weiner L.M. Monoclonal antibody therapy of cancer. Nat. Biotechnol. 23 (2005) 1147
    • (2005) Nat. Biotechnol. , vol.23 , pp. 1147
    • Adams, G.P.1    Weiner, L.M.2
  • 2
    • 0345596439 scopus 로고    scopus 로고
    • Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver
    • Alexander Jr. H.R., Bartlett D.L., Libutti S.K., Fraker D.L., Moser T., and Rosenberg S.A. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. J. Clin. Oncol. 16 (1998) 1479
    • (1998) J. Clin. Oncol. , vol.16 , pp. 1479
    • Alexander Jr., H.R.1    Bartlett, D.L.2    Libutti, S.K.3    Fraker, D.L.4    Moser, T.5    Rosenberg, S.A.6
  • 3
    • 0032535052 scopus 로고    scopus 로고
    • Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor
    • Armitage J.O. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood 92 (1998) 4491
    • (1998) Blood , vol.92 , pp. 4491
    • Armitage, J.O.1
  • 4
    • 0030889207 scopus 로고    scopus 로고
    • The IFN gamma receptor: a paradigm for cytokine receptor signaling
    • Bach E.A., Aguet M., and Schreiber R.D. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15 (1997) 563
    • (1997) Annu. Rev. Immunol. , vol.15 , pp. 563
    • Bach, E.A.1    Aguet, M.2    Schreiber, R.D.3
  • 5
    • 33646407812 scopus 로고    scopus 로고
    • Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin
    • Balza E., Mortara L., Sassi F., Monteghirfo S., Carnemolla B., Castellani P., Neri D., Accolla R.S., Zardi L., and Borsi L. Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin. Clin. Cancer Res. 12 (2006) 2575
    • (2006) Clin. Cancer Res. , vol.12 , pp. 2575
    • Balza, E.1    Mortara, L.2    Sassi, F.3    Monteghirfo, S.4    Carnemolla, B.5    Castellani, P.6    Neri, D.7    Accolla, R.S.8    Zardi, L.9    Borsi, L.10
  • 6
    • 0029890827 scopus 로고    scopus 로고
    • T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy
    • Becker J.C., Pancook J.D., Gillies S.D., Furukawa K., and Reisfeld R.A. T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy. J. Exp. Med. 183 (1996) 2361
    • (1996) J. Exp. Med. , vol.183 , pp. 2361
    • Becker, J.C.1    Pancook, J.D.2    Gillies, S.D.3    Furukawa, K.4    Reisfeld, R.A.5
  • 8
    • 0032827243 scopus 로고    scopus 로고
    • Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment
    • Birchler M., Viti F., Zardi L., Spiess B., and Neri D. Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment. Nat. Biotechnol. 17 (1999) 984
    • (1999) Nat. Biotechnol. , vol.17 , pp. 984
    • Birchler, M.1    Viti, F.2    Zardi, L.3    Spiess, B.4    Neri, D.5
  • 14
    • 0034716486 scopus 로고    scopus 로고
    • Therapeutic monoclonal antibodies
    • Breedveld F.C. Therapeutic monoclonal antibodies. Lancet 355 (2000) 735
    • (2000) Lancet , vol.355 , pp. 735
    • Breedveld, F.C.1
  • 16
    • 0024594936 scopus 로고
    • A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors
    • Carnemolla B., Balza E., Siri A., Zardi L., Nicotra M.R., Bigotti A., and Natali P.G. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J. Cell Biol. 108 (1989) 1139
    • (1989) J. Cell Biol. , vol.108 , pp. 1139
    • Carnemolla, B.1    Balza, E.2    Siri, A.3    Zardi, L.4    Nicotra, M.R.5    Bigotti, A.6    Natali, P.G.7
  • 17
    • 0036493867 scopus 로고    scopus 로고
    • Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix
    • Carnemolla B., Borsi L., Balza E., Castellani P., Meazza R., Berndt A., Ferrini S., Kosmehl H., Neri D., and Zardi L. Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix. Blood 99 (2002) 1659
    • (2002) Blood , vol.99 , pp. 1659
    • Carnemolla, B.1    Borsi, L.2    Balza, E.3    Castellani, P.4    Meazza, R.5    Berndt, A.6    Ferrini, S.7    Kosmehl, H.8    Neri, D.9    Zardi, L.10
  • 18
    • 0029802551 scopus 로고    scopus 로고
    • Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain
    • Carnemolla B., Neri D., Castellani P., Leprini A., Neri G., Pini A., Winter G., and Zardi L. Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain. Int. J. Cancer 68 (1996) 397
    • (1996) Int. J. Cancer , vol.68 , pp. 397
    • Carnemolla, B.1    Neri, D.2    Castellani, P.3    Leprini, A.4    Neri, G.5    Pini, A.6    Winter, G.7    Zardi, L.8
  • 19
    • 45749104147 scopus 로고    scopus 로고
    • Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study
    • Cartron G., Zhao-Yang L., Baudard M., Kanouni T., Rouille V., Quittet P., Klein B., and Rossi J.F. Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study. J. Clin. Oncol. 26 (2008) 2725
    • (2008) J. Clin. Oncol. , vol.26 , pp. 2725
    • Cartron, G.1    Zhao-Yang, L.2    Baudard, M.3    Kanouni, T.4    Rouille, V.5    Quittet, P.6    Klein, B.7    Rossi, J.F.8
  • 20
    • 0036841992 scopus 로고    scopus 로고
    • Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin
    • Castellani P., Borsi L., Carnemolla B., Biro A., Dorcaratto A., Viale G.L., Neri D., and Zardi L. Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin. Am. J. Pathol. 161 (2002) 1695
    • (2002) Am. J. Pathol. , vol.161 , pp. 1695
    • Castellani, P.1    Borsi, L.2    Carnemolla, B.3    Biro, A.4    Dorcaratto, A.5    Viale, G.L.6    Neri, D.7    Zardi, L.8
  • 22
    • 0028824039 scopus 로고
    • IL-12 deaths: explanation and a puzzle
    • Cohen J. IL-12 deaths: explanation and a puzzle. Science 270 (1995) 908
    • (1995) Science , vol.270 , pp. 908
    • Cohen, J.1
  • 23
    • 0036005890 scopus 로고    scopus 로고
    • Interleukin-12 in anti-tumor immunity and immunotherapy
    • Colombo M.P., and Trinchieri G. Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev. 13 (2002) 155
    • (2002) Cytokine Growth Factor Rev. , vol.13 , pp. 155
    • Colombo, M.P.1    Trinchieri, G.2
  • 24
    • 0036369434 scopus 로고    scopus 로고
    • In vivo tumor delivery of a recombinant single chain Fv::tumor necrosis factor-alpha fusion [correction of factor: a fusion] protein
    • Cooke S.P., Pedley R.B., Boden R., Begent R.H., and Chester K.A. In vivo tumor delivery of a recombinant single chain Fv::tumor necrosis factor-alpha fusion [correction of factor: a fusion] protein. Bioconjug. Chem. 13 (2002) 7
    • (2002) Bioconjug. Chem. , vol.13 , pp. 7
    • Cooke, S.P.1    Pedley, R.B.2    Boden, R.3    Begent, R.H.4    Chester, K.A.5
  • 25
    • 33644789357 scopus 로고    scopus 로고
    • Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients
    • Correale P., Cusi M.G., Tsang K.Y., Del Vecchio M.T., Marsili S., Placa M.L., Intrivici C., Aquino A., Micheli L., Nencini C., Ferrari F., Giorgi G., Bonmassar E., and Francini G. Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients. J. Clin. Oncol. 23 (2005) 8950
    • (2005) J. Clin. Oncol. , vol.23 , pp. 8950
    • Correale, P.1    Cusi, M.G.2    Tsang, K.Y.3    Del Vecchio, M.T.4    Marsili, S.5    Placa, M.L.6    Intrivici, C.7    Aquino, A.8    Micheli, L.9    Nencini, C.10    Ferrari, F.11    Giorgi, G.12    Bonmassar, E.13    Francini, G.14
  • 26
    • 23844494526 scopus 로고    scopus 로고
    • Immunotherapy of renal cell carcinoma with granulocyte macrophage colony stimulating factor and very low dose interleukin-2
    • Correale P., Marsili S., Sabatino M., Montagnani F., Giorgi G., and Francini G. Immunotherapy of renal cell carcinoma with granulocyte macrophage colony stimulating factor and very low dose interleukin-2. Oncol. Rep. 13 (2005) 751
    • (2005) Oncol. Rep. , vol.13 , pp. 751
    • Correale, P.1    Marsili, S.2    Sabatino, M.3    Montagnani, F.4    Giorgi, G.5    Francini, G.6
  • 27
    • 1642434101 scopus 로고    scopus 로고
    • Coupling tumor necrosis factor-alpha with alphaV integrin ligands improves its antineoplastic activity
    • Curnis F., Gasparri A., Sacchi A., Longhi R., and Corti A., Coupling tumor necrosis factor-alpha with alphaV integrin ligands improves its antineoplastic activity. Cancer Res. 64 (2004) 565
    • (2004) Cancer Res. , vol.64 , pp. 565
    • Curnis, F.1    Gasparri, A.2    Sacchi, A.3    Longhi, R.4    Corti, A.5
  • 28
    • 0033764170 scopus 로고    scopus 로고
    • Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)
    • Curnis F., Sacchi A., Borgna L., Magni F., Gasparri A., and Corti A. Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). Nat. Biotechnol. 18 (2000) 1185
    • (2000) Nat. Biotechnol. , vol.18 , pp. 1185
    • Curnis, F.1    Sacchi, A.2    Borgna, L.3    Magni, F.4    Gasparri, A.5    Corti, A.6
  • 30
    • 8644240039 scopus 로고    scopus 로고
    • Antibody-cytokine fusion proteins: innovative weapons in the war against cancer
    • Dela Cruz J.S., Huang T.H., Penichet M.L., and Morrison S.L. Antibody-cytokine fusion proteins: innovative weapons in the war against cancer. Clin. Exp. Med. 4 (2004) 57
    • (2004) Clin. Exp. Med. , vol.4 , pp. 57
    • Dela Cruz, J.S.1    Huang, T.H.2    Penichet, M.L.3    Morrison, S.L.4
  • 31
    • 0037471398 scopus 로고    scopus 로고
    • Protein vaccination with the HER2/neu extracellular domain plus anti-HER2/neu antibody-cytokine fusion proteins induces a protective anti-HER2/neu immune response in mice
    • Dela Cruz J.S., Lau S.Y., Ramirez E.M., De Giovanni C., Forni G., Morrison S.L., and Penichet M.L. Protein vaccination with the HER2/neu extracellular domain plus anti-HER2/neu antibody-cytokine fusion proteins induces a protective anti-HER2/neu immune response in mice. Vaccine 21 (2003) 1317
    • (2003) Vaccine , vol.21 , pp. 1317
    • Dela Cruz, J.S.1    Lau, S.Y.2    Ramirez, E.M.3    De Giovanni, C.4    Forni, G.5    Morrison, S.L.6    Penichet, M.L.7
  • 32
    • 0034327810 scopus 로고    scopus 로고
    • Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity
    • Dela Cruz J.S., Trinh K.R., Morrison S.L., and Penichet M.L. Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity. J. Immunol. 165 (2000) 5112
    • (2000) J. Immunol. , vol.165 , pp. 5112
    • Dela Cruz, J.S.1    Trinh, K.R.2    Morrison, S.L.3    Penichet, M.L.4
  • 34
    • 0019955969 scopus 로고
    • Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses
    • Djeu J.Y., Stocks N., Zoon K., Stanton G.J., Timonen T., and Herberman R.B. Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses. J. Exp. Med. 156 (1982) 1222
    • (1982) J. Exp. Med. , vol.156 , pp. 1222
    • Djeu, J.Y.1    Stocks, N.2    Zoon, K.3    Stanton, G.J.4    Timonen, T.5    Herberman, R.B.6
  • 36
    • 0029738520 scopus 로고    scopus 로고
    • Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial
    • Eggermont A.M., Schraffordt Koops H., Lienard D., Kroon B.B., van Geel A.N., Hoekstra H.J., and Lejeune F.J. Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J. Clin. Oncol. 14 (1996) 2653
    • (1996) J. Clin. Oncol. , vol.14 , pp. 2653
    • Eggermont, A.M.1    Schraffordt Koops, H.2    Lienard, D.3    Kroon, B.B.4    van Geel, A.N.5    Hoekstra, H.J.6    Lejeune, F.J.7
  • 38
    • 0027411525 scopus 로고
    • The molecular cell biology of interferon-gamma and its receptor
    • Farrar M.A., and Schreiber R.D. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11 (1993) 571
    • (1993) Annu. Rev. Immunol. , vol.11 , pp. 571
    • Farrar, M.A.1    Schreiber, R.D.2
  • 39
    • 0025877853 scopus 로고
    • Genetic construction and characterization of a fusion protein consisting of a chimeric F(ab') with specificity for carcinomas and human IL-2
    • Fell H.P., Gayle M.A., Grosmaire L., and Ledbetter J.A. Genetic construction and characterization of a fusion protein consisting of a chimeric F(ab') with specificity for carcinomas and human IL-2. J. Immunol. 146 (1991) 2446
    • (1991) J. Immunol. , vol.146 , pp. 2446
    • Fell, H.P.1    Gayle, M.A.2    Grosmaire, L.3    Ledbetter, J.A.4
  • 40
    • 0023700112 scopus 로고
    • Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function
    • Fischer H.G., Frosch S., Reske K., and Reske-Kunz A.B. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function. J. Immunol. 141 (1988) 3882
    • (1988) J. Immunol. , vol.141 , pp. 3882
    • Fischer, H.G.1    Frosch, S.2    Reske, K.3    Reske-Kunz, A.B.4
  • 41
    • 0027467414 scopus 로고
    • Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability
    • Folli S., Pelegrin A., Chalandon Y., Yao X., Buchegger F., Lienard D., Lejeune F., and Mach J.P. Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability. Int. J. Cancer 53 (1993) 829
    • (1993) Int. J. Cancer , vol.53 , pp. 829
    • Folli, S.1    Pelegrin, A.2    Chalandon, Y.3    Yao, X.4    Buchegger, F.5    Lienard, D.6    Lejeune, F.7    Mach, J.P.8
  • 42
    • 0036790091 scopus 로고    scopus 로고
    • Mice lacking the EDB segment of fibronectin develop normally but exhibit reduced cell growth and fibronectin matrix assembly in vitro
    • Fukuda T., Yoshida N., Kataoka Y., Manabe R., Mizuno-Horikawa Y., Sato M., Kuriyama K., Yasui N., and Sekiguchi K. Mice lacking the EDB segment of fibronectin develop normally but exhibit reduced cell growth and fibronectin matrix assembly in vitro. Cancer Res. 62 (2002) 5603
    • (2002) Cancer Res. , vol.62 , pp. 5603
    • Fukuda, T.1    Yoshida, N.2    Kataoka, Y.3    Manabe, R.4    Mizuno-Horikawa, Y.5    Sato, M.6    Kuriyama, K.7    Yasui, N.8    Sekiguchi, K.9
  • 43
    • 33748866249 scopus 로고    scopus 로고
    • An engineered antibody-interleukin-12 fusion protein with enhanced tumor vascular targeting properties
    • Gafner V., Trachsel E., and Neri D. An engineered antibody-interleukin-12 fusion protein with enhanced tumor vascular targeting properties. Int. J. Cancer 119 (2006) 2205
    • (2006) Int. J. Cancer , vol.119 , pp. 2205
    • Gafner, V.1    Trachsel, E.2    Neri, D.3
  • 44
    • 0025604195 scopus 로고
    • Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity
    • Gansbacher B., Bannerji R., Daniels B., Zier K., Cronin K., and Gilboa E. Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res. 50 (1990) 7820
    • (1990) Cancer Res. , vol.50 , pp. 7820
    • Gansbacher, B.1    Bannerji, R.2    Daniels, B.3    Zier, K.4    Cronin, K.5    Gilboa, E.6
  • 45
    • 0036042603 scopus 로고    scopus 로고
    • Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer
    • Gillies S.D., Lan Y., Brunkhorst B., Wong W.K., Li Y., and Lo K.M. Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer. Cancer Immunol. Immunother. 51 (2002) 449
    • (2002) Cancer Immunol. Immunother. , vol.51 , pp. 449
    • Gillies, S.D.1    Lan, Y.2    Brunkhorst, B.3    Wong, W.K.4    Li, Y.5    Lo, K.M.6
  • 46
    • 0027598183 scopus 로고
    • Biological activity and in vivo clearance of antitumor antibody/cytokine fusion proteins
    • Gillies S.D., Young D., Lo K.M., and Roberts S. Biological activity and in vivo clearance of antitumor antibody/cytokine fusion proteins. Bioconjug. Chem. 4 (1993) 230
    • (1993) Bioconjug. Chem. , vol.4 , pp. 230
    • Gillies, S.D.1    Young, D.2    Lo, K.M.3    Roberts, S.4
  • 47
    • 0023932445 scopus 로고
    • Clearance and distribution of recombinant murine gamma-interferon in mice
    • Gonias S.L., Pizzo S.V., and Hoffman M. Clearance and distribution of recombinant murine gamma-interferon in mice. Cancer Res. 48 (1988) 2021
    • (1988) Cancer Res. , vol.48 , pp. 2021
    • Gonias, S.L.1    Pizzo, S.V.2    Hoffman, M.3
  • 49
    • 32844472410 scopus 로고    scopus 로고
    • Technology insight: Utility of TNF-alpha-based isolated limb perfusion to avoid amputation of irresectable tumors of the extremities
    • Grunhagen D.J., de Wilt J.H., ten Hagen T.L., and Eggermont A.M. Technology insight: Utility of TNF-alpha-based isolated limb perfusion to avoid amputation of irresectable tumors of the extremities. Nat. Clin. Pract. Oncol. 3 (2006) 94
    • (2006) Nat. Clin. Pract. Oncol. , vol.3 , pp. 94
    • Grunhagen, D.J.1    de Wilt, J.H.2    ten Hagen, T.L.3    Eggermont, A.M.4
  • 50
    • 0037731516 scopus 로고    scopus 로고
    • Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha
    • Halin C., Gafner V., Villani M.E., Borsi L., Berndt A., Kosmehl H., Zardi L., and Neri D. Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha. Cancer Res. 63 (2003) 3202
    • (2003) Cancer Res. , vol.63 , pp. 3202
    • Halin, C.1    Gafner, V.2    Villani, M.E.3    Borsi, L.4    Berndt, A.5    Kosmehl, H.6    Zardi, L.7    Neri, D.8
  • 51
    • 0036194917 scopus 로고    scopus 로고
    • Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature
    • Halin C., Rondini S., Nilsson F., Berndt A., Kosmehl H., Zardi L., and Neri D. Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature. Nat. Biotechnol. 20 (2002) 264
    • (2002) Nat. Biotechnol. , vol.20 , pp. 264
    • Halin, C.1    Rondini, S.2    Nilsson, F.3    Berndt, A.4    Kosmehl, H.5    Zardi, L.6    Neri, D.7
  • 52
    • 0030267660 scopus 로고    scopus 로고
    • In vivo properties of an IgG3-IL-2 fusion protein. A general strategy for immune potentiation
    • Harvill E.T., Fleming J.M., and Morrison S.L. In vivo properties of an IgG3-IL-2 fusion protein. A general strategy for immune potentiation. J. Immunol. 157 (1996) 3165
    • (1996) J. Immunol. , vol.157 , pp. 3165
    • Harvill, E.T.1    Fleming, J.M.2    Morrison, S.L.3
  • 54
    • 2442710337 scopus 로고    scopus 로고
    • Engineering a thermostable human prolyl endopeptidase for antibody-directed enzyme prodrug therapy
    • Heinis C., Alessi P., and Neri D. Engineering a thermostable human prolyl endopeptidase for antibody-directed enzyme prodrug therapy. Biochemistry 43 (2004) 6293
    • (2004) Biochemistry , vol.43 , pp. 6293
    • Heinis, C.1    Alessi, P.2    Neri, D.3
  • 56
    • 0024539057 scopus 로고
    • Structure of tumour necrosis factor
    • Jones E.Y., Stuart D.I., and Walker N.P. Structure of tumour necrosis factor. Nature 338 (1989) 225
    • (1989) Nature , vol.338 , pp. 225
    • Jones, E.Y.1    Stuart, D.I.2    Walker, N.P.3
  • 57
    • 0028131531 scopus 로고
    • Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues
    • Kaczmarek J., Castellani P., Nicolo G., Spina B., Allemanni G., and Zardi L. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int. J. Cancer 59 (1994) 11
    • (1994) Int. J. Cancer , vol.59 , pp. 11
    • Kaczmarek, J.1    Castellani, P.2    Nicolo, G.3    Spina, B.4    Allemanni, G.5    Zardi, L.6
  • 58
    • 34250315638 scopus 로고    scopus 로고
    • The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis
    • Kaspar M., Trachsel E., and Neri D. The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis. Cancer Res. 67 (2007) 4940
    • (2007) Cancer Res. , vol.67 , pp. 4940
    • Kaspar, M.1    Trachsel, E.2    Neri, D.3
  • 59
    • 33644518982 scopus 로고    scopus 로고
    • Fibronectin as target for tumor therapy
    • Kaspar M., Zardi L., and Neri D. Fibronectin as target for tumor therapy. Int. J. Cancer 118 (2006) 1331
    • (2006) Int. J. Cancer , vol.118 , pp. 1331
    • Kaspar, M.1    Zardi, L.2    Neri, D.3
  • 61
    • 0027407459 scopus 로고
    • Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions
    • Kirchhofer D., Sakariassen K.S., Clozel M., Tschopp T.B., Hadvary P., Nemerson Y., and Baumgartner H.R. Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions. Blood 81 (1993) 2050
    • (1993) Blood , vol.81 , pp. 2050
    • Kirchhofer, D.1    Sakariassen, K.S.2    Clozel, M.3    Tschopp, T.B.4    Hadvary, P.5    Nemerson, Y.6    Baumgartner, H.R.7
  • 62
    • 0029758308 scopus 로고    scopus 로고
    • Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts
    • Kristensen C.A., Nozue M., Boucher Y., and Jain R.K. Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts. Br. J. Cancer 74 (1996) 533
    • (1996) Br. J. Cancer , vol.74 , pp. 533
    • Kristensen, C.A.1    Nozue, M.2    Boucher, Y.3    Jain, R.K.4
  • 63
    • 0021969122 scopus 로고
    • Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients
    • Kurzrock R., Rosenblum M.G., Sherwin S.A., Rios A., Talpaz M., Quesada J.R., and Gutterman J.U. Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients. Cancer Res. 45 (1985) 2866
    • (1985) Cancer Res. , vol.45 , pp. 2866
    • Kurzrock, R.1    Rosenblum, M.G.2    Sherwin, S.A.3    Rios, A.4    Talpaz, M.5    Quesada, J.R.6    Gutterman, J.U.7
  • 65
    • 0026531756 scopus 로고
    • High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma
    • Lienard D., Ewalenko P., Delmotte J.J., Renard N., and Lejeune F.J. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J. Clin. Oncol. 10 (1992) 52
    • (1992) J. Clin. Oncol. , vol.10 , pp. 52
    • Lienard, D.1    Ewalenko, P.2    Delmotte, J.J.3    Renard, N.4    Lejeune, F.J.5
  • 66
    • 0033843152 scopus 로고    scopus 로고
    • Targeted cytokines for cancer immunotherapy
    • Lode H.N., and Reisfeld R.A. Targeted cytokines for cancer immunotherapy. Immunol. Res. 21 (2000) 279
    • (2000) Immunol. Res. , vol.21 , pp. 279
    • Lode, H.N.1    Reisfeld, R.A.2
  • 67
    • 0032031429 scopus 로고    scopus 로고
    • Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy
    • Lode H.N., Xiang R., Dreier T., Varki N.M., Gillies S.D., and Reisfeld R.A. Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy. Blood 91 (1998) 1706
    • (1998) Blood , vol.91 , pp. 1706
    • Lode, H.N.1    Xiang, R.2    Dreier, T.3    Varki, N.M.4    Gillies, S.D.5    Reisfeld, R.A.6
  • 69
    • 0024384319 scopus 로고
    • IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells
    • Maraskovsky E., Chen W.F., and Shortman K. IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells. J. Immunol. 143 (1989) 1210
    • (1989) J. Immunol. , vol.143 , pp. 1210
    • Maraskovsky, E.1    Chen, W.F.2    Shortman, K.3
  • 70
  • 71
    • 0026748230 scopus 로고
    • Polyethylene-glycol-modified interleukin-2 is superior to interleukin-2 in locoregional immunotherapy of established guinea-pig tumors
    • Mattijssen V., Balemans L.T., Steerenberg P.A., and De Mulder P.H. Polyethylene-glycol-modified interleukin-2 is superior to interleukin-2 in locoregional immunotherapy of established guinea-pig tumors. Int. J. Cancer 51 (1992) 812
    • (1992) Int. J. Cancer , vol.51 , pp. 812
    • Mattijssen, V.1    Balemans, L.T.2    Steerenberg, P.A.3    De Mulder, P.H.4
  • 73
    • 0036891467 scopus 로고    scopus 로고
    • An antibody-calmodulin fusion protein reveals a functional dependence between macromolecular isoelectric point and tumor targeting performance
    • Melkko S., Halin C., Borsi L., Zardi L., and Neri D. An antibody-calmodulin fusion protein reveals a functional dependence between macromolecular isoelectric point and tumor targeting performance. Int. J. Radiat. Oncol. Biol. Phys. 54 (2002) 1485
    • (2002) Int. J. Radiat. Oncol. Biol. Phys. , vol.54 , pp. 1485
    • Melkko, S.1    Halin, C.2    Borsi, L.3    Zardi, L.4    Neri, D.5
  • 74
    • 21244499009 scopus 로고    scopus 로고
    • ED-B fibronectin as a target for antibody-based cancer treatments
    • Menrad A., and Menssen H.D. ED-B fibronectin as a target for antibody-based cancer treatments. Expert Opin. Ther. Targets 9 (2005) 491
    • (2005) Expert Opin. Ther. Targets , vol.9 , pp. 491
    • Menrad, A.1    Menssen, H.D.2
  • 75
    • 0033983271 scopus 로고    scopus 로고
    • Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells
    • Midulla M., Verma R., Pignatelli M., Ritter M.A., Courtenay-Luck N.S., and George A.J. Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells. Cancer Res. 60 (2000) 164
    • (2000) Cancer Res. , vol.60 , pp. 164
    • Midulla, M.1    Verma, R.2    Pignatelli, M.3    Ritter, M.A.4    Courtenay-Luck, N.S.5    George, A.J.6
  • 76
    • 0023244861 scopus 로고
    • Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells
    • Morrissey P.J., Bressler L., Park L.S., Alpert A., and Gillis S. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J. Immunol. 139 (1987) 1113
    • (1987) J. Immunol. , vol.139 , pp. 1113
    • Morrissey, P.J.1    Bressler, L.2    Park, L.S.3    Alpert, A.4    Gillis, S.5
  • 78
    • 0026034432 scopus 로고
    • Role of nitric oxide synthesis in macrophage antimicrobial activity
    • Nathan C.F., and Hibbs Jr. J.B. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3 (1991) 65
    • (1991) Curr. Opin. Immunol. , vol.3 , pp. 65
    • Nathan, C.F.1    Hibbs Jr., J.B.2
  • 81
    • 0035863566 scopus 로고    scopus 로고
    • Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice
    • Nilsson F., Kosmehl H., Zardi L., and Neri D. Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice. Cancer Res. 61 (2001) 711
    • (2001) Cancer Res. , vol.61 , pp. 711
    • Nilsson, F.1    Kosmehl, H.2    Zardi, L.3    Neri, D.4
  • 82
    • 0022369998 scopus 로고
    • Tumor necrosis factor (TNF)
    • Old L.J. Tumor necrosis factor (TNF). Science 230 (1985) 630
    • (1985) Science , vol.230 , pp. 630
    • Old, L.J.1
  • 84
    • 0037107551 scopus 로고    scopus 로고
    • Fibronectin at a glance
    • Pankov R., and Yamada K.M. Fibronectin at a glance. J. Cell Sci. 115 (2002) 3861
    • (2002) J. Cell Sci. , vol.115 , pp. 3861
    • Pankov, R.1    Yamada, K.M.2
  • 85
    • 0035251612 scopus 로고    scopus 로고
    • Antibody-cytokine fusion proteins for the therapy of cancer
    • Penichet M.L., and Morrison S.L. Antibody-cytokine fusion proteins for the therapy of cancer. J. Immunol. Methods 248 (2001) 91
    • (2001) J. Immunol. Methods , vol.248 , pp. 91
    • Penichet, M.L.1    Morrison, S.L.2
  • 87
    • 0029038921 scopus 로고
    • Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1
    • Roake J.A., Rao A.S., Morris P.J., Larsen C.P., Hankins D.F., and Austyn J.M. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 181 (1995) 2237
    • (1995) J. Exp. Med. , vol.181 , pp. 2237
    • Roake, J.A.1    Rao, A.S.2    Morris, P.J.3    Larsen, C.P.4    Hankins, D.F.5    Austyn, J.M.6
  • 88
    • 0032748338 scopus 로고    scopus 로고
    • Interleukin-12 as an adjuvant for cancer immunotherapy
    • Rodolfo M., and Colombo M.P. Interleukin-12 as an adjuvant for cancer immunotherapy. Methods 19 (1999) 114
    • (1999) Methods , vol.19 , pp. 114
    • Rodolfo, M.1    Colombo, M.P.2
  • 89
    • 0033847583 scopus 로고    scopus 로고
    • Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer
    • Rosenberg S.A. Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer. Cancer J. Sci. Am. 6 Suppl. 1 (2000) 2
    • (2000) Cancer J. Sci. Am. , vol.6 , Issue.SUPPL. 1 , pp. 2
    • Rosenberg, S.A.1
  • 90
    • 0029038828 scopus 로고
    • An antimelanoma immunotoxin containing recombinant human tumor necrosis factor: tissue disposition, pharmacokinetic, and therapeutic studies in xenograft models
    • Rosenblum M.G., Cheung L., Mujoo K., and Murray J.L. An antimelanoma immunotoxin containing recombinant human tumor necrosis factor: tissue disposition, pharmacokinetic, and therapeutic studies in xenograft models. Cancer Immunol. Immunother. 40 (1995) 322
    • (1995) Cancer Immunol. Immunother. , vol.40 , pp. 322
    • Rosenblum, M.G.1    Cheung, L.2    Mujoo, K.3    Murray, J.L.4
  • 91
    • 0028060152 scopus 로고
    • A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice
    • Sabzevari H., Gillies S.D., Mueller B.M., Pancook J.D., and Reisfeld R.A. A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice. Proc. Natl. Acad Sci. USA 91 (1994) 9626
    • (1994) Proc. Natl. Acad Sci. USA , vol.91 , pp. 9626
    • Sabzevari, H.1    Gillies, S.D.2    Mueller, B.M.3    Pancook, J.D.4    Reisfeld, R.A.5
  • 94
    • 0027512894 scopus 로고
    • A recombinant single chain antibody interleukin-2 fusion protein
    • Savage P., So A., Spooner R.A., and Epenetos A.A. A recombinant single chain antibody interleukin-2 fusion protein. Br. J. Cancer 67 (1993) 304
    • (1993) Br. J. Cancer , vol.67 , pp. 304
    • Savage, P.1    So, A.2    Spooner, R.A.3    Epenetos, A.A.4
  • 95
    • 33644834222 scopus 로고    scopus 로고
    • A human cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM overexpressing tumor cells
    • Schanzer J.M., Baeuerle P.A., Dreier T., and Kufer P. A human cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM overexpressing tumor cells. Cancer Immun. 6 (2006) 4
    • (2006) Cancer Immun. , vol.6 , pp. 4
    • Schanzer, J.M.1    Baeuerle, P.A.2    Dreier, T.3    Kufer, P.4
  • 96
    • 0030070734 scopus 로고    scopus 로고
    • Eastern cooperative group trial of interferon gamma in metastatic melanoma: an innovative study design
    • Schiller J.H., Pugh M., Kirkwood J.M., Karp D., Larson M., and Borden E. Eastern cooperative group trial of interferon gamma in metastatic melanoma: an innovative study design. Clin. Cancer Res. 2 (1996) 29
    • (1996) Clin. Cancer Res. , vol.2 , pp. 29
    • Schiller, J.H.1    Pugh, M.2    Kirkwood, J.M.3    Karp, D.4    Larson, M.5    Borden, E.6
  • 97
    • 35848962936 scopus 로고    scopus 로고
    • Antibody-based targeting of the tumor vasculature
    • Schliemann C., and Neri D. Antibody-based targeting of the tumor vasculature. Biochim. Biophys. Acta 1776 (2007) 175
    • (2007) Biochim. Biophys. Acta , vol.1776 , pp. 175
    • Schliemann, C.1    Neri, D.2
  • 98
  • 100
    • 0021042241 scopus 로고
    • Three different fibronectin mRNAs arise by alternative splicing within the coding region
    • Schwarzbauer J.E., Tamkun J.W., Lemischka I.R., and Hynes R.O. Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell 35 (1983) 421
    • (1983) Cell , vol.35 , pp. 421
    • Schwarzbauer, J.E.1    Tamkun, J.W.2    Lemischka, I.R.3    Hynes, R.O.4
  • 101
    • 54949101585 scopus 로고    scopus 로고
    • Cytokines and their relationship to the symptoms and outcome of cancer
    • Seruga B., Zhang H., Bernstein L.J., and Tannock I.F. Cytokines and their relationship to the symptoms and outcome of cancer. Nat. Rev. Cancer 8 (2008) 887
    • (2008) Nat. Rev. Cancer , vol.8 , pp. 887
    • Seruga, B.1    Zhang, H.2    Bernstein, L.J.3    Tannock, I.F.4
  • 104
    • 0023226808 scopus 로고
    • Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice
    • Talmadge J.E., Tribble H.R., Pennington R.W., Phillips H., and Wiltrout R.H. Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice. Cancer Res. 47 (1987) 2563
    • (1987) Cancer Res. , vol.47 , pp. 2563
    • Talmadge, J.E.1    Tribble, H.R.2    Pennington, R.W.3    Phillips, H.4    Wiltrout, R.H.5
  • 105
    • 0027394657 scopus 로고
    • The IL-2/IL-2 receptor system: a current overview
    • Taniguchi T., and Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell 73 (1993) 5
    • (1993) Cell , vol.73 , pp. 5
    • Taniguchi, T.1    Minami, Y.2
  • 107
    • 0024541450 scopus 로고
    • Macroscopic and microscopic early effects of tumour necrosis factor on murine Meth A sarcoma, and relation to curative activity
    • Van de Wiel P.A., Bloksma N., Kuper C.F., Hofhuis F.M., and Willers J.M. Macroscopic and microscopic early effects of tumour necrosis factor on murine Meth A sarcoma, and relation to curative activity. J. Pathol. 157 (1989) 65
    • (1989) J. Pathol. , vol.157 , pp. 65
    • Van de Wiel, P.A.1    Bloksma, N.2    Kuper, C.F.3    Hofhuis, F.M.4    Willers, J.M.5
  • 108
    • 0031873440 scopus 로고    scopus 로고
    • Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-alpha in soft tissue sarcoma bearing rats
    • van der Veen A.H., Eggermont A.M., Seynhaeve A.L., van T., and ten Hagen T.L. Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-alpha in soft tissue sarcoma bearing rats. Int. J. Cancer 77 (1998) 901
    • (1998) Int. J. Cancer , vol.77 , pp. 901
    • van der Veen, A.H.1    Eggermont, A.M.2    Seynhaeve, A.L.3    van, T.4    ten Hagen, T.L.5
  • 110
    • 0033555628 scopus 로고    scopus 로고
    • Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis
    • Viti F., Tarli L., Giovannoni L., Zardi L., and Neri D. Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis. Cancer Res. 59 (1999) 347
    • (1999) Cancer Res. , vol.59 , pp. 347
    • Viti, F.1    Tarli, L.2    Giovannoni, L.3    Zardi, L.4    Neri, D.5
  • 112
    • 33746547247 scopus 로고    scopus 로고
    • The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
    • Waldmann T.A. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6 (2006) 595
    • (2006) Nat. Rev. Immunol. , vol.6 , pp. 595
    • Waldmann, T.A.1
  • 115
    • 0034662638 scopus 로고    scopus 로고
    • Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein
    • Xu X., Clarke P., Szalai G., Shively J.E., Williams L.E., Shyr Y., Shi E., and Primus F.J. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein. Cancer Res. 60 (2000) 4475
    • (2000) Cancer Res. , vol.60 , pp. 4475
    • Xu, X.1    Clarke, P.2    Szalai, G.3    Shively, J.E.4    Williams, L.E.5    Shyr, Y.6    Shi, E.7    Primus, F.J.8
  • 116
    • 0028289170 scopus 로고
    • Antitumor potential of interferon-gamma: retroviral expression of mouse interferon-gamma cDNA in two kinds of highly metastatic mouse tumor lines reduces their tumorigenicity
    • Yanagihara K., Seyama T., and Watanabe Y. Antitumor potential of interferon-gamma: retroviral expression of mouse interferon-gamma cDNA in two kinds of highly metastatic mouse tumor lines reduces their tumorigenicity. Nat. Immun. 13 (1994) 102
    • (1994) Nat. Immun. , vol.13 , pp. 102
    • Yanagihara, K.1    Seyama, T.2    Watanabe, Y.3
  • 117
    • 0019363174 scopus 로고
    • Monoclonal antibodies: a powerful new tool in biology and medicine
    • Yelton D.E., and Scharff M.D. Monoclonal antibodies: a powerful new tool in biology and medicine. Annu. Rev. Biochem. 50 (1981) 657
    • (1981) Annu. Rev. Biochem. , vol.50 , pp. 657
    • Yelton, D.E.1    Scharff, M.D.2
  • 119
    • 0023392493 scopus 로고
    • Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon
    • Zardi L., Carnemolla B., Siri A., Petersen T.E., Paolella G., Sebastio G., and Baralle F.E. Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J. 6 (1987) 2337
    • (1987) EMBO J. , vol.6 , pp. 2337
    • Zardi, L.1    Carnemolla, B.2    Siri, A.3    Petersen, T.E.4    Paolella, G.5    Sebastio, G.6    Baralle, F.E.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.